Your browser doesn't support javascript.
loading
Neurally Adjusted Ventilatory Assist in Very Prematurely Born Infants with Evolving/Established Bronchopulmonary Dysplasia.
Shetty, Sandeep; Evans, Katie; Cornuaud, Peter; Kulkarni, Anay; Duffy, Donovan; Greenough, Anne.
Affiliation
  • Shetty S; Neonatal Intensive Care Centre, St George's University Hospitals NHS Foundation Trust, London, United Kingdom.
  • Evans K; Department of Neonatal Medicine, St George's University of London, London, United Kingdom.
  • Cornuaud P; Neonatal Intensive Care Centre, St George's University Hospitals NHS Foundation Trust, London, United Kingdom.
  • Kulkarni A; Neonatal Intensive Care Centre, St George's University Hospitals NHS Foundation Trust, London, United Kingdom.
  • Duffy D; Neonatal Intensive Care Centre, St George's University Hospitals NHS Foundation Trust, London, United Kingdom.
  • Greenough A; Neonatal Intensive Care Centre, St George's University Hospitals NHS Foundation Trust, London, United Kingdom.
AJP Rep ; 11(4): e127-e131, 2021 Oct.
Article in En | MEDLINE | ID: mdl-34849284
ABSTRACT
Background During neurally adjusted ventilatory assist (NAVA)/noninvasive (NIV) NAVA, a modified nasogastric feeding tube with electrodes monitors the electrical activity of the diaphragm (Edi). The Edi waveform determines the delivered pressure from the ventilator. Objective Our objective was to determine whether NAVA/NIV-NAVA has advantages in infants with evolving/established bronchopulmonary dysplasia (BPD). Methods Each infant who received NAVA/NIV-NAVA and conventional invasive and NIV was matched with two historical controls. Eighteen NAVA/NIV-NAVA infants' median gestational age, 25.3 (23.6-28.1) weeks, was compared with 36 historical controls' median gestational age 25.2 (23.1-29.1) weeks. Results Infants on NAVA/NIV-NAVA had lower extubation failure rates (median 0 [0-2] vs. 1 [0-6] p = 0.002), shorter durations of invasive ventilation (median 30.5, [1-90] vs. 40.5 [11-199] days, p = 0.046), and total duration of invasive and NIV to the point of discharge to the local hospital (median 80 [57-140] vs. 103.5 [60-246] days, p = 0.026). The overall length of stay (LOS) was lower in NAVA/NIVNAVA group (111.5 [78-183] vs. 140 [82-266] days, p = 0.019). There were no significant differences in BPD (17/18 [94%] vs. 32/36 [89%] p = 0.511) or home oxygen rates (14/18 [78%] vs. 23/36 [64%] p = 0.305). Conclusion The combination of NAVA/NIV-NAVA compared with conventional invasive and NIV modes may be advantageous for preterm infants with evolving/established BPD.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: AJP Rep Year: 2021 Document type: Article Affiliation country: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: AJP Rep Year: 2021 Document type: Article Affiliation country: United kingdom